EE9900543A - Parendatud oraalse absorbtsiooniga ja bioomastatavusega HIV proteaasi inhibiitori sulfaatsool - Google Patents

Parendatud oraalse absorbtsiooniga ja bioomastatavusega HIV proteaasi inhibiitori sulfaatsool

Info

Publication number
EE9900543A
EE9900543A EEP199900543A EEP9900543A EE9900543A EE 9900543 A EE9900543 A EE 9900543A EE P199900543 A EEP199900543 A EE P199900543A EE P9900543 A EEP9900543 A EE P9900543A EE 9900543 A EE9900543 A EE 9900543A
Authority
EE
Estonia
Prior art keywords
bioavailability
protease inhibitor
hiv protease
oral absorption
sulphate salt
Prior art date
Application number
EEP199900543A
Other languages
English (en)
Estonian (et)
Inventor
Askin David
Scott Hoerrner R.
M. Purick Robert
Reider Paul
J. Varsolona Richard
P. Volante Ralph
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9714320.0A external-priority patent/GB9714320D0/en
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of EE9900543A publication Critical patent/EE9900543A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP199900543A 1997-05-29 1998-05-26 Parendatud oraalse absorbtsiooniga ja bioomastatavusega HIV proteaasi inhibiitori sulfaatsool EE9900543A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4795097P 1997-05-29 1997-05-29
GBGB9714320.0A GB9714320D0 (en) 1997-07-07 1997-07-07 Hiv protease inhibitor
PCT/US1998/010633 WO1998054178A1 (en) 1997-05-29 1998-05-26 Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability

Publications (1)

Publication Number Publication Date
EE9900543A true EE9900543A (et) 2000-06-15

Family

ID=26311845

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900543A EE9900543A (et) 1997-05-29 1998-05-26 Parendatud oraalse absorbtsiooniga ja bioomastatavusega HIV proteaasi inhibiitori sulfaatsool

Country Status (22)

Country Link
EP (1) EP0986554A1 (xx)
JP (1) JP3267632B2 (xx)
KR (1) KR20010013042A (xx)
CN (1) CN1257497A (xx)
AU (1) AU730245B2 (xx)
BG (1) BG103923A (xx)
BR (1) BR9809498A (xx)
CA (1) CA2291086A1 (xx)
EA (1) EA199901095A1 (xx)
EE (1) EE9900543A (xx)
HR (1) HRP980283A2 (xx)
HU (1) HUP0004621A3 (xx)
ID (1) ID23858A (xx)
IL (1) IL132779A0 (xx)
IS (1) IS5240A (xx)
NO (1) NO995822L (xx)
PE (1) PE75099A1 (xx)
PL (1) PL336847A1 (xx)
SK (1) SK163299A3 (xx)
TR (1) TR199902816T2 (xx)
TW (1) TW438799B (xx)
WO (1) WO1998054178A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001038332A1 (en) * 1999-11-24 2001-05-31 Merck & Co., Inc. Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors
AU2001290743A1 (en) * 2000-09-14 2002-03-26 Ortho-Mcneil Pharmaceutical, Inc. Solid salt forms of n-(2-(4-(2-(1-methylethoxy)phenyl)-1-piperazinyl)ethyl)-2-oxo-1-piperidineacetamide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT74681A (en) * 1993-12-15 1997-01-28 Merck & Co Inc N-(2-hydroxy-1-indenyl)-2-phenylmethyl-4-hydroxy-5-(2-carboxamido-piperazinyl)-pentaneamide derivatives of hiv protease inhibitor activity and phrmaceutical compositions contining them

Also Published As

Publication number Publication date
EP0986554A1 (en) 2000-03-22
TW438799B (en) 2001-06-07
BR9809498A (pt) 2000-06-20
IL132779A0 (en) 2001-03-19
KR20010013042A (ko) 2001-02-26
TR199902816T2 (xx) 2000-02-21
JP3267632B2 (ja) 2002-03-18
NO995822D0 (no) 1999-11-26
EA199901095A1 (ru) 2000-08-28
HUP0004621A2 (hu) 2002-03-28
SK163299A3 (en) 2000-07-11
JP2000513747A (ja) 2000-10-17
CA2291086A1 (en) 1998-12-03
NO995822L (no) 2000-01-28
BG103923A (en) 2000-06-30
ID23858A (id) 2000-05-25
HRP980283A2 (en) 1999-08-31
HUP0004621A3 (en) 2002-04-29
AU730245B2 (en) 2001-03-01
AU7595998A (en) 1998-12-30
WO1998054178A1 (en) 1998-12-03
IS5240A (is) 1999-11-09
PL336847A1 (en) 2000-07-17
PE75099A1 (es) 1999-08-11
CN1257497A (zh) 2000-06-21

Similar Documents

Publication Publication Date Title
EE200000725A (et) Uued 3-arüülpropaanhappe derivaadid ja nende analoogid
FI960635L (fi) Elektrodi ja sen valmistus
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
DE69823016D1 (de) Wässrige lösungen von salicylsaure derivaten
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
EE04904B1 (et) Tiobensimidasooli derivaadid ja farmatseutiline kompositsioon
EE200000798A (et) HIV proteaasi inhibiitori bisulfaatsool
DE69502726D1 (de) Hestellung von aniontensidgranulaten
EE200100632A (et) Amlodipiini ja atorvastatiini ühine sool
FI970317A7 (fi) Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä
EP1009377A4 (en) MEDICAL USE OF PYRUVATES
EE200200146A (et) Loteprednooli ja antihistamiinsete ainete uudne kombinatsioon
DE69514830D1 (de) Coproduktion von kaliumsulfat und natriumsulfat
EE200000506A (et) Meta-asatsüklilised aminobensoehappeühendid ja nende derivaadid integriini antagonistidena
DE69907146T2 (de) Direkte oxidation von cycloalkanen
FI971711L (fi) Levobupivakaiinin ja sen analogien kiteyttäminen
DE69508812D1 (de) Sulfoniumsalz und chemisch verstärkte Positivresistzusammensetzungen
PT878467E (pt) Acidos 6-aminotetra-hidroisoquinolinacarboxilicos e 7-aminotetra-hidroisoquinolinacarboxilicos substituidos
EE200100051A (et) Vastavast (-)-stereoisomeerist põhiliselt vaba (+)-nortsisapriidi või selle farmatseutiliselt vastuvõetava soola kasutamine ja farmatseutiline kompositsioon
FI956116A7 (fi) N-fosfonometyyliglysiinin ja sen suolojen valmistus
EE9900543A (et) Parendatud oraalse absorbtsiooniga ja bioomastatavusega HIV proteaasi inhibiitori sulfaatsool
EE200100017A (et) N-tert-butüülhüdroksüülamiini uued soolad
DE69400693D1 (de) Minderung von NOx-Emissionen
FI962019A7 (fi) Pyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina ainein a
DE69502429D1 (de) Auflösung von Gas